Dapavo P - Search Results

1

Drug survival, effectiveness, and safety of guselkumab for moderate-to-severe psoriasis for up to 4 years.

Mastorino L, Dapavo P, Ortoncelli M, Stroppiana E, Verrone A, Astrua C, Fiasconaro C, Liao Y, Gallo G, Quaglino P, Ribero S. Mastorino L, et al. Among authors: dapavo p. Clin Exp Dermatol. 2025 Jan 8:llaf010. doi: 10.1093/ced/llaf010. Online ahead of print. Clin Exp Dermatol. 2025. PMID: 39775848

2

Efficacy, safety, and drug survival of IL-23, IL-17, and TNF-alpha inhibitors for psoriasis treatment: a retrospective study.

Dapavo P, Siliquini N, Mastorino L, Avallone G, Merli M, Agostini A, Cariti C, Viola R, Stroppiana E, Verrone A, Ortoncelli M, Quaglino P, Ribero S. Dapavo P, et al. J Dermatolog Treat. 2022 Jun;33(4):2352-2357. doi: 10.1080/09546634.2021.1961998. Epub 2021 Aug 13. J Dermatolog Treat. 2022. PMID: 34315331 Free article.

3

Seven cancer patients receiving guselkumab for treatment of moderate-to-severe psoriasis.

Mastorino L, Siliquini N, Avallone G, Ortoncelli M, Quaglino P, Dapavo P, Ribero S. Mastorino L, et al. Among authors: dapavo p. Dermatol Reports. 2022 Mar 17;14(3):9282. doi: 10.4081/dr.2022.9282. eCollection 2022 Sep 14. Dermatol Reports. 2022. PMID: 36199899 Free PMC article. No abstract available.

4

"Superresponders" at biologic treatment for psoriasis: A comparative study among IL17 and IL23 inhibitors.

Mastorino L, Susca S, Cariti C, Verrone A, Stroppiana E, Ortoncelli M, Dapavo P, Ribero S, Quaglino P. Mastorino L, et al. Among authors: dapavo p. Exp Dermatol. 2023 Dec;32(12):2187-2188. doi: 10.1111/exd.14731. Epub 2022 Dec 26. Exp Dermatol. 2023. PMID: 36541075 No abstract available.

5

Drug survival and efficacy of anti-interleukin 23 biologics in psoriasis: a comparative study on different agents.

Roccuzzo G, Mastorino L, Susca S, Cariti C, Passerini SG, Sciamarrelli N, Borriello S, Macagno N, Sliquini N, Avallone G, Verrone A, Stroppiana E, Quaglino P, Ortoncelli M, Dapavo P, Ribero S. Roccuzzo G, et al. Among authors: dapavo p. Clin Exp Dermatol. 2023 Mar 22;48(4):379-381. doi: 10.1093/ced/llac098. Clin Exp Dermatol. 2023. PMID: 36745578 No abstract available.

6

Impact of comorbidities in elderly and frail patients and response to biological therapy in psoriasis.

Rosset F, Mastorino L, Dapavo P, Quaglino P, Ribero S. Rosset F, et al. Among authors: dapavo p. Exp Dermatol. 2023 Jul;32(7):1162-1164. doi: 10.1111/exd.14822. Epub 2023 Apr 26. Exp Dermatol. 2023. PMID: 37098693 No abstract available.

7

Comparison between brodalumab, secukinumab and ixekizumab effectiveness and drug survival: A real-life experience on 638 patients with psoriasis.

Mastorino L, Cariti C, Susca S, Siliquini N, Verrone A, Stroppiana E, Ortoncelli M, Dapavo P, Quaglino P, Ribero S. Mastorino L, et al. Among authors: dapavo p. Exp Dermatol. 2023 Sep;32(9):1591-1594. doi: 10.1111/exd.14874. Epub 2023 Jul 3. Exp Dermatol. 2023. PMID: 37395012 No abstract available.

8

Drug survival and clinical effectiveness of secukinumab, ixekizumab, brodalumab, guselkumab, risankizumab, tildrakizumab for psoriasis treatment.

Mastorino L, Dapavo P, Susca S, Cariti C, Siliquini N, Verrone A, Stroppiana E, Ortoncelli M, Quaglino P, Ribero S. Mastorino L, et al. Among authors: dapavo p. J Dtsch Dermatol Ges. 2024 Jan;22(1):34-42. doi: 10.1111/ddg.15251. Epub 2023 Nov 5. J Dtsch Dermatol Ges. 2024. PMID: 37926830

9

Drug survival, effectiveness and safety of ixekizumab for moderate-to-severe psoriasis up to 5 years.

Mastorino L, Dapavo P, Burzi L, Rosset F, Giunipero di Corteranzo I, Leo F, Verrone A, Stroppiana E, Ortoncelli M, Ribero S, Quaglino P. Mastorino L, et al. Among authors: dapavo p. J Eur Acad Dermatol Venereol. 2024 Mar;38(3):568-575. doi: 10.1111/jdv.19682. Epub 2023 Dec 26. J Eur Acad Dermatol Venereol. 2024. PMID: 38147467

10

Drug survival, effectiveness, and safety of brodalumab for moderate-to-severe psoriasis up to 3 years.

Mastorino L, Dapavo P, Burzi L, Rosset F, Giunipero di Corteranzo I, Leo F, Verrone A, Stroppiana E, Ortoncelli M, Ribero S, Quaglino P. Mastorino L, et al. Among authors: dapavo p. Int J Dermatol. 2024 Jul;63(7):922-928. doi: 10.1111/ijd.17038. Epub 2024 Jan 29. Int J Dermatol. 2024. PMID: 38284277

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

152 results

Search Page

Filters